Unknown

Dataset Information

Molecular Determinants of Soft Tissue Sarcoma Immunity: Targets for Immune Intervention.


ABSTRACT: Soft tissue sarcomas (STSs) are a family of rare malignant tumors encompassing more than 80 histologies. Current therapies for metastatic STS, a condition that affects roughly half of patients, have limited efficacy, making innovative therapeutic strategies urgently needed. From a molecular point of view, STSs can be classified as translocation-related and those with a heavily rearranged genotype. Although only the latter display an increased mutational burden, molecular profiles suggestive of an "immune hot" tumor microenvironment are observed across STS histologies, and response to immunotherapy has been reported in both translocation-related and genetic complex STSs. These data reinforce the notion that immunity in STSs is multifaceted and influenced by both genetic and epigenetic deter

SUBMITTER: Tazzari M 

PROVIDER: S-EPMC8303572 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature